CORNERSTONE SPECIALTY LITTLE ROCK
1. Target Overview & Investment Thesis
CORNERSTONE SPECIALTY LITTLE ROCK is a 40-bed suburban community hospital in PULASKI, AR with $15.2M in net patient revenue and a 4.2% operating margin. The hospital serves a payer mix of 44.1% Medicare, 2.0% Medicaid, and 53.9% commercial.
Thesis: Turnaround. Our ML models identify $1.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 4.2% to 11.6% (+736bps).
| Net Revenue HCRIS | $15.2M |
| Current EBITDA COMPUTED | $638K |
| Operating Margin COMPUTED | 4.2% |
| Occupancy HCRIS | 57.5% |
| Revenue / Bed COMPUTED | $381K |
| Net-to-Gross HCRIS | 23.4% |
| Distress Probability ML | 46.8% |
2. Market Context & Competitive Position
AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 4.2% places it above the state median. Among 65 size-comparable peers (20-80 beds), the median margin is -11.5%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (20-80), prioritizing same-state peers. 65 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CORNERSTONE SPECIALTY LITTLE R (Target) | AR | 40 | $15.2M | 4.2% |
| ARKANSAS CHILDRENS NORTHWEST | AR | 24 | $113.6M | 7.2% |
| SILOAM SPRINGS MEMORIAL HOSPIT | AR | 64 | $85.0M | 8.4% |
| ARKANSAS SURGICAL HOSPITAL | AR | 47 | $75.1M | 11.7% |
| ST VINCENT NORTH | AR | 68 | $72.1M | -18.7% |
| ENCORE MEDICAL CENTER | AR | 25 | $55.7M | -4.7% |
| OZARKS COMMUNITY HOSPITAL OF G | AR | 25 | $48.6M | -21.0% |
| ENCOMPASS HEALTH REHABILITATIO | AR | 80 | $36.3M | 27.9% |
| DREW MEMORIAL HOSPITAL INC | AR | 49 | $35.3M | -27.2% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $320K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $304K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $301K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $185K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $638K |
| + RCM Uplift | +$1.1M |
| Pro Forma EBITDA | $1.8M |
| Current Margin | 4.2% |
| Pro Forma Margin | 11.6% |
| WC Released (1x) | $584K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $982K | $15.4M | 15.70x | 73.5% |
| Base (11x exit) | 10.0x | 11.0x | $982K | $17.3M | 17.59x | 77.4% |
| Bull Case | 9.0x | 11.0x | $884K | $21.3M | 24.09x | 89.0% |
| Bull (12x exit) | 9.0x | 12.0x | $884K | $23.5M | 26.58x | 92.7% |
| Bear Case | 11.0x | 10.0x | $1.1M | $9.5M | 8.79x | 54.4% |
| Bear (11x exit) | 11.0x | 11.0x | $1.1M | $10.8M | 9.99x | 58.5% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Standard execution risk | RCM improvement requires management buy-in and 12-18 month implementation timeline |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 65 hospitals with 20-80 beds
- Same-state prioritization (n=66)
- Comp margins: P25=-23.0% / P50=-11.5% / P75=6.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.